SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $879,167 | -60.2% | 369,398 | -19.9% | 0.00% | – |
Q2 2023 | $2,209,005 | +100.6% | 461,170 | +137.5% | 0.00% | – |
Q1 2023 | $1,101,204 | -10.2% | 194,216 | -11.3% | 0.00% | – |
Q4 2022 | $1,225,964 | +60.3% | 218,922 | +83.4% | 0.00% | – |
Q3 2022 | $765,000 | -0.6% | 119,375 | -46.9% | 0.00% | – |
Q2 2022 | $770,000 | -81.8% | 224,636 | -62.3% | 0.00% | -100.0% |
Q1 2022 | $4,241,000 | -6.5% | 595,521 | +9.3% | 0.00% | 0.0% |
Q4 2021 | $4,537,000 | -4.3% | 544,717 | -20.1% | 0.00% | 0.0% |
Q3 2021 | $4,743,000 | -68.3% | 681,435 | +8.5% | 0.00% | -50.0% |
Q2 2021 | $14,975,000 | +105.6% | 627,851 | +77.5% | 0.00% | +100.0% |
Q1 2021 | $7,284,000 | +96.8% | 353,758 | +134.1% | 0.00% | 0.0% |
Q4 2020 | $3,701,000 | +34.0% | 151,092 | +54.9% | 0.00% | 0.0% |
Q3 2020 | $2,762,000 | +475.4% | 97,547 | -3.3% | 0.00% | – |
Q2 2020 | $480,000 | +37.9% | 100,862 | +3.5% | 0.00% | – |
Q1 2020 | $348,000 | -29.8% | 97,497 | -32.2% | 0.00% | – |
Q4 2019 | $496,000 | +4.9% | 143,879 | +22.0% | 0.00% | – |
Q3 2019 | $473,000 | +2.8% | 117,959 | -17.4% | 0.00% | – |
Q2 2019 | $460,000 | -75.4% | 142,890 | -47.5% | 0.00% | -100.0% |
Q1 2019 | $1,871,000 | +139.9% | 272,334 | +57.8% | 0.00% | – |
Q4 2018 | $780,000 | -41.5% | 172,624 | -1.7% | 0.00% | – |
Q3 2018 | $1,334,000 | -6.7% | 175,573 | +5.6% | 0.00% | – |
Q2 2018 | $1,430,000 | -2.1% | 166,217 | -16.5% | 0.00% | – |
Q1 2018 | $1,461,000 | +32.6% | 199,063 | +83.3% | 0.00% | – |
Q4 2017 | $1,102,000 | +37.4% | 108,623 | +117.1% | 0.00% | – |
Q3 2017 | $802,000 | +157.9% | 50,033 | +82.0% | 0.00% | – |
Q2 2017 | $311,000 | -69.3% | 27,498 | -69.4% | 0.00% | – |
Q1 2017 | $1,012,000 | -44.9% | 89,724 | -51.7% | 0.00% | – |
Q4 2016 | $1,838,000 | +134.4% | 185,644 | +190.9% | 0.00% | – |
Q3 2016 | $784,000 | -23.4% | 63,823 | +81.2% | 0.00% | – |
Q2 2016 | $1,023,000 | -16.2% | 35,215 | -23.5% | 0.00% | – |
Q1 2016 | $1,221,000 | +3.0% | 46,010 | +36.3% | 0.00% | – |
Q4 2015 | $1,185,000 | +286.0% | 33,758 | +225.3% | 0.00% | – |
Q3 2015 | $307,000 | +195.2% | 10,377 | +315.1% | 0.00% | – |
Q2 2015 | $104,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |